scifigal2k said...
I had what my GI called the "Prometheus test" as a blood test to see if I had any antibodies to Remicade or if I even had Remicade in my system still (it was at week 7). That knowledge helped my GI realize that Remicade wasn't working because I needed it more frequently and not because I had built up antibodies to it.
The tests that they use are experimental and unnecessary according to my insurance company, so they would not cover the tests. That cap of $250 was applied to me as well. I appreciated that they were willing to do a cap and not just be out to make money. They aren't a scam, and their test was vital to me because we probably would have just stopped doing Remicade and switched to Humira and assumed that I had antibodies to the Remicade. I am very grateful that I could stay on Remicade, just with more frequent infusions. I'd like to use it as long as it's effective and hold off on Humira for as long as possible.
So I would find out from your GI exactly what test he wants done and what information it will give him so that you can decide if it is worth the $250 or not.
The Prometheus test for detecting antibodies to Remicade (ati's - antibodies to infliximab) is pretty new, so insurance companies are reluctant to cover it; but it's a critical test for some patients. As you stated, it helps determine why Remicade may not be working or is losing effectiveness. I expect that over time the insurance companies will start to realize the importance of this test and then they'll start approving it more often. After all, it could save them money by not having patients waste Remicade infusions that aren't helping them.